Sunday, July 22, 2018
Company News: Page (1) of 1 - 07/10/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Chronic Care Management, Inc. Releases Clinical Performance Outcomes
Company is Helping Patients and Providers Achieve Low Hospitalization and Readmission Rates By Leveraging Evidence-Based Medicine
(July 10, 2018)

CLEVELAND, July 10, 2018 /PRNewswire/ -- Chronic Care Management, Inc. announced today that is has released clinical outcomes on its managed population for the first half of 2018.

Dr. William Mills, President and CEO of Chronic Care Management, Inc. said, "We are pleased to be the first chronic care management patient and practice support organization to publicly release clinical and utilization outcomes for our managed population. Reporting of outcomes drives transparency and illustrates the value of evidence-based attention to 'in-between visit care.'" A video presentation overview of the company's outcomes presented by Dr. Mills can be viewed on the company's homepage.

The company reported that between January and June of 2018, CCM Inc. managed over 21,000 patients in its full-service, clinically-integrated model, in addition to supporting the management of thousands of additional patients in practice-staffed care management models. The company supported low hospitalization and readmission rates by leveraging evidence-based outcome assessment tools to provide high-impact, low-cost touchpoints to patients with chronic medical and behavioral conditions. Dr. Mills said, "The key to our approach is that we focus entirely on using medical science and evidence-based workflow to drive the identification of clinical risks. We then link patients with identified risks to community resources such as home health, physical therapy, caregivers and other resources in close collaboration with the patient's medical provider. This approach has helped us identify patients at high risk of falls, adverse drug interactions, 12-month mortality and many other important areas – which then enable us to help patients' providers deploy resources to address such risks."

CCM is a program launched by the Centers for Medicare and Medicaid Services (CMS) in 2015 to help  provide support for patients with multiple chronic conditions in-between their provider visits and episodes of care. The CCM program created a new Medicare-benefit to support beneficiaries with two or more chronic conditions by providing new "in-between visit" revenue to participating providers, stimulating practices to enhance their focus on goal-directed, person-centered care planning, and to provide "aging-in-place" resources such as proactive care management.

The CCM program is associated with positive clinical outcomes for patients – a recent study of the Medicare program showed that it is lowering hospitalization rates, emergency department use and skilled nursing days, while increasing engagement between patients and their practitioners. The program works by creating increased connectivity between patients with chronic conditions and their healthcare providers and matching patients with community-based resources such as home healthcare when appropriate.

About Chronic Care Management, Inc.

Chronic Care Management, Inc. is a solution-oriented technology and services care management provider. The company's primary focus is "in-between visit" care management for people with multiple chronic conditions. Headed by William Mills, M.D., a physician with extensive national care management leadership and primary care and geriatrics practice, the company develops and deploys software and clinically integrated care management programs that promote goal-directed, quality collaborative care planning. The solutions bring together healthcare providers, systems, and stakeholders around a central, person-centered care plan that drive positive clinical outcomes for patients and positive financial outcomes for healthcare organizations and payers, including Medicare. Providing fee-for-service healthcare providers a concrete path from volume to value, Chronic Care Management, also empowers organizations who are participating in alternative payment models with a formal platform to foster care coordination, quality measure success attainment, advance care planning, care transitions, medication reconciliation and a number of other success-driving areas.

For more information, or to schedule a product and services presentation, please visit or call toll free: (844) CCM-6500/(844) 226-6500.

© 2018 Chronic Care Management, Inc. and the Chronic Care Management company name with logo are registered trademarks of Chronic Care Management, Inc. All rights reserved.

Press Contact:

Kathy Lewis, Chronic Care Management, Inc.

(844) 226-6500 | [email protected]

Cision View original content:

SOURCE Chronic Care Management, Inc.

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Video, Inc.,Medicine,Aging,Insurance,healthcare,Surgery,Medication,Seniors Health,Seniors,Physician,Insurance Companies,Science,Medical,Science,Other,Medical Professionals,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines